No Detail Found!

Efficacy of Rituximab Combined with Glucocorticoid for Nephrotic Syndrome and the Impact on Renal Function, Coagulation Function, and In ammatory Response

Author(s)
Si Shi Department of Nephrology, Jingmen Central Hospital,Jingmen,China
Jie Zeng Department of Nephrology, Xianyang Central Hospital,Xianyang,China
Yang Liu Department of Nephrology, Jingmen Central Hospital,Jingmen,China
Bingquan Li Department of Nephrology, Xianyang Central Hospital,Xianyang,China
Abstract
To explore the e cacy of rituximab combined with glucocorticoid for nephrotic syndrome and the impact on renal function, coagulation function, and in ammatory response. Study Design: Observational study. Place and Duration of the Study: Department of Nephrology, Xianyang Central Hospital, Xianyang, China, from February 2021 to 2023. Methodology: Sixty patients with nephrotic syndrome were divided into the control group and the observation group, which received glucocorticoid prednisone and rituximab combined with prednisone for treatment for six months, respectively. Results: At the end of the treatment, the total e ective rate and the serum albumin level remarkably increased, while the serum creatinine, 24-hour urine protein levels and the serum brinogen, D-dimer, C-reactive protein, interleukin, and tumour necrosis factor ± levels were remarkably decreased (p <0.05) in the observation group as compared to the control group. Conclusion: Rituximab combined with glucocorticoid e ectively enhances the patient's renal and coagulation functions, while decreasing the in ammatory response in nephrotic syndrome.
Publication Details
Page(s) 871-874
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 07, Year: 2025

Request the full text from PASTIC

Keywords
Coagulation, Nephrotic syndrome, Rituximab, Glucocorticoid, In ammatory response
References
Rodriguez-Ballestas E,Reid-Adam J .2022 .Nephrotic syndrome. Pediatr Rev, 00(2) : 87-99.
Nogueira M,Cartwright J,Horn K,Doe N,Shappell S,Barrios R .2000 .Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am J Kidney Dis, 6386(00) : 70033-3.
Zhao QC,Li WN,Li ZJ,Li Y,Sun DH Y . .E ect of voriconazole combined with glucocorticoid on nephrotic syndrome in children. Eur Rev Med Pharmacol, 10(15) : 26458-25.
Broek MVD,Smeets B,Schreuder MF,Jansen J. .2022 .The podocyte as a direct target of glucocorticoids in nephrotic syndrome. Nephrol Dial Transplant, 10(10) : 1808-15.
Trautmann A,Vivarelli M,Samuel S,Gipson D,Sinha A,Schaefer F .2020 .IPNA clinical practice recommendations for the diagnosis and management of children with steroidresistant nephrotic syndrome. Pediatr Nephrol, 10(8) : 1529-61.
Theiler-Schwetz V,Prete A .2023 .Glucocorticoid withdrawal syndrome: what to expect and how to manage. Curr Opin Endocrinol Diabetes Obes, 10(3) : 167-74.
Ryan ST,Zhang J,Burner DN,Liss M,Pittman E,Muldong M .2020 .Neoadjuvant rituximab modulates the tumour immune environment in patients with high risk prostate cancer. J Transl Med, 10(1) : 020.
Jeruschke S,Alex D,Hoyer PF,Weber S. Protective .2022 .e ects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes. Sci Rep, 10(1) : 12297.
Tian Y,Sun B,Sun G .2023 .Research progress of nephrotic syndrome accompanied by thromboembolism. Int Urol Nephrol, 10(7) : 1735-45.
Barbano B,Gigante A,Amoroso A,Cianci R. .2013 .Thrombosis in nephrotic syndrome. Semin Thromb Hemost, 10(5) : 469-76.
Gerstein J,Battu K .2023 .Prophylactic anticoagulation in nephrotic syndrome. Kidney360, 10(10) : 1476-8.
Rasedee A,Feldman BF .1985 .Nephrotic syndrome: A platelet hyperaggregability state. Vet Res Commun, 10(3) : 199-211.
Mulat SY,Mihajlovic M,Antonic T,Milosevski-Lomic G,PecoAntic A,Jovanovic D .2024 .Pediatric nephrotic syndrome: The interplay of oxidative stress and in ammationJ. Med Biochem, 10(4) : 46526-35.
Nakamori A,Akagaki F,Yamaguchi Y,Arima R,Sugiura T. .2018 .Nephrotic syndrome with thrombocytopenia, lymphadenopathy, systemic in ammation, and splenomegaly. Intern Med, 9556(8) : 17-9.
Dogra GK,Herrmann S,Irish AB,Thomas MA,Watts GF .2002 .Insulin resistance, dyslipidaemia, in ammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant, 10(12) : 2220-5.
Roca N,Martinez C,Jatem E,Madrid A,Lopez M,Segarra A .2021 .Activation of the acute in ammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids. Clin Kidney J, 10(4) : 1207-5.
Zhou HH,Tang YL,Xu TH .2024 .C-reactive protein: Structure, function, regulation, and role in clinical diseases. Front Immunol, 15 : 1425168.
Sproston NR,Ashworth JJ .2018 .Role of C-reactive protein at sites of in ammation and infection. Front Immunol, 00754 : 754.
Alves LV,Martins SR,Simoes E Silva AC,Cardoso CN,Gomes KB,Mota APL .2024 .TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation. Immunol Res, 1425168(5) : 246-54.
Wang Y,Zhang H,Chen Q,Jiao F,Shi C,Pei M .2020 ./ HMGB1 in ammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif, 10(6) : .
0

Citations

0

Downloads

65

Views